Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v14-FR Version v3-EN
Language French English
Date Updated 2017-11-02 2017-04-13
Drug Identification Number 02357984 02357984
Brand name MYLAN-RISEDRONATE MYLAN-RISEDRONATE
Common or Proper name Risedronate Risedronate
Company Name MYLAN PHARMACEUTICALS ULC MYLAN PHARMACEUTICALS ULC
Ingredients RISEDRONATE SODIUM RISEDRONATE SODIUM
Strength(s) 35MG 35MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 30BT 30
ATC code M05BA M05BA
ATC description DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date 2017-11-01 2017-09-02
Actual start date
Estimated end date Unknown
Actual end date 2017-11-01
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments Discontinued as per date in ID 16151
Health Canada comments